ArticleBlood advances2026

Predictors of posttransplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

Abiola Bolarinwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.